CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

725 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 663 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46,743,700 shares of 50,495,188 outstanding shares and own 92.57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,922,050 shares), BlackRock Inc. (5,087,693 shares), FMR LLC (2,823,913 shares), STATE STREET CORP (1,957,480 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1,481,805 shares), Invesco Ltd. (1,467,311 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,357,246 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (942,596 shares), GEODE CAPITAL MANAGEMENT, LLC (911,152 shares), and ROYAL BANK OF CANADA (719,297 shares).
This table shows the top 663 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.